Skip to Main Content

Paper Details

Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine.
EBioMedicine
30
2022
Author NameAffiliation
Kimberly Meade-WhiteNational Institute of Allergy and Infectious Diseases, National Institutes of Health
Deepashri RaoNational Institute of Allergy and Infectious Diseases, National Institutes of Health
Alexander L GreningerUniversity of Washington School of Medicine
Michael GaleCenter for Innate Immunity and Immune Disease, University of Washington School of Medicine
  • 1 - 4

Datasets